David M Printzenhoff

David M Printzenhoff currently works at Icagen, Inc. where he uses automated electrophysiological test equipment and techniques for drug candidate discovery. David does research in Physiology, Neuroscience and Cell Biology. His most recent publication is 'Highly potent and selective NaV 1.7 inhibitors for use as intravenous agents and chemical probes'.